Connection

DAVID GRAHAM to Peptic Ulcer

This is a "connection" page, showing publications DAVID GRAHAM has written about Peptic Ulcer.
Connection Strength

6.772
  1. Upper Gastrointestinal Bleeding Due to a Peptic Ulcer. N Engl J Med. 2016 09 22; 375(12):1197-8.
    View in: PubMed
    Score: 0.482
  2. Helicobacter pylori infection--a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter. 2013 Oct; 18(5):338-46.
    View in: PubMed
    Score: 0.380
  3. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009 May; 10(2):77-84.
    View in: PubMed
    Score: 0.289
  4. Gastritis, dyspepsia and peptic ulcer disease. Minerva Med. 2008 Jun; 99(3):323-33.
    View in: PubMed
    Score: 0.271
  5. Ulcers and gastritis. Endoscopy. 2008 Feb; 40(2):136-9.
    View in: PubMed
    Score: 0.262
  6. Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy. Ann Intern Med. 2007 Sep 18; 147(6):434-5.
    View in: PubMed
    Score: 0.258
  7. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 2006 Sep; 52(3):235-48.
    View in: PubMed
    Score: 0.240
  8. Endoscopic ulcers with low-dose aspirin and reality testing. Gastroenterology. 2005 Mar; 128(3):807; author reply 807--8.
    View in: PubMed
    Score: 0.216
  9. Is the use of COX-2 inhibitors in gastroenterology cost-effective? Nat Clin Pract Gastroenterol Hepatol. 2004 Dec; 1(2):60-1.
    View in: PubMed
    Score: 0.213
  10. Ulcers and gastritis. Endoscopy. 2004 Jan; 36(1):42-7.
    View in: PubMed
    Score: 0.200
  11. Changing patterns of peptic ulcer, gastro-oesophageal reflux disease and Helicobacter pylori: a unifying hypothesis. Eur J Gastroenterol Hepatol. 2003 May; 15(5):571-2.
    View in: PubMed
    Score: 0.190
  12. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter. 2002 Feb; 7(1):1-8.
    View in: PubMed
    Score: 0.175
  13. Helicobacter pylori infection and the use of NSAIDs. Best Pract Res Clin Gastroenterol. 2001 Oct; 15(5):775-85.
    View in: PubMed
    Score: 0.171
  14. Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy. Helicobacter. 2001 Mar; 6(1):66-76.
    View in: PubMed
    Score: 0.164
  15. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Am J Med. 2001 Jan 08; 110(1A):58S-61S.
    View in: PubMed
    Score: 0.162
  16. Ulcer and gastritis. Endoscopy. 2001 Jan; 33(1):8-15.
    View in: PubMed
    Score: 0.162
  17. Hemostatic spray powder TC-325 in the primary endoscopic treatment of peptic ulcer-related bleeding: multicenter international registry. Endoscopy. 2021 01; 53(1):36-43.
    View in: PubMed
    Score: 0.155
  18. One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. Dig Dis Sci. 1998 Mar; 43(3):464-7.
    View in: PubMed
    Score: 0.133
  19. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Am J Gastroenterol. 1996 Oct; 91(10):2080-6.
    View in: PubMed
    Score: 0.121
  20. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol. 1996 Oct; 49(10):829-32.
    View in: PubMed
    Score: 0.121
  21. Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. Dig Dis Sci. 2016 11; 61(11):3215-3220.
    View in: PubMed
    Score: 0.121
  22. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1996 Aug; 10(4):617-21.
    View in: PubMed
    Score: 0.119
  23. Low point prevalence of peptic ulcer in normal individuals with Helicobacter pylori infection. Am J Gastroenterol. 1996 Jun; 91(6):1112-5.
    View in: PubMed
    Score: 0.118
  24. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther. 1996 Feb; 10(1):119-22.
    View in: PubMed
    Score: 0.115
  25. Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur J Clin Microbiol Infect Dis. 1995 Apr; 14(4):349-52.
    View in: PubMed
    Score: 0.109
  26. Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients. Intern Emerg Med. 2015 Oct; 10(7):787-94.
    View in: PubMed
    Score: 0.108
  27. Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1994 Apr; 8(2):259-62.
    View in: PubMed
    Score: 0.102
  28. Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Curr Pharm Des. 2014; 20(28):4510-6.
    View in: PubMed
    Score: 0.100
  29. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol. 1993 Nov; 28(11):939-42.
    View in: PubMed
    Score: 0.099
  30. Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol. 2013 08; 10(8):495-500.
    View in: PubMed
    Score: 0.096
  31. Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases. J Clin Microbiol. 2012 Feb; 50(2):441-8.
    View in: PubMed
    Score: 0.086
  32. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology. 1991 Jun; 100(6):1653-7.
    View in: PubMed
    Score: 0.083
  33. The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease. Gastroenterol Clin North Am. 1990 Mar; 19(1):171-82.
    View in: PubMed
    Score: 0.076
  34. Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol. 2009 Nov; 47(11):3493-500.
    View in: PubMed
    Score: 0.074
  35. Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis. 2008 Jul; 40(7):497-503.
    View in: PubMed
    Score: 0.067
  36. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis. 1988 Apr; 157(4):777-80.
    View in: PubMed
    Score: 0.067
  37. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol. 2005 May; 40(5):523-9.
    View in: PubMed
    Score: 0.055
  38. Why do apparently healthy people use antacid tablets? Am J Gastroenterol. 1983 May; 78(5):257-60.
    View in: PubMed
    Score: 0.048
  39. Recurrent ulcers after gastric surgery: endoscopic localization to the gastric mucosa. Am J Gastroenterol. 1983 May; 78(5):269-71.
    View in: PubMed
    Score: 0.048
  40. NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med. 2002 Dec 26; 347(26):2162-4.
    View in: PubMed
    Score: 0.046
  41. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10.
    View in: PubMed
    Score: 0.046
  42. Are genetic influences on peptic ulcer dependent or independent of genetic influences for Helicobacter pylori infection? Arch Intern Med. 2000 Jan 10; 160(1):105-9.
    View in: PubMed
    Score: 0.038
  43. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 1999 Nov 24; 282(20):1921-8.
    View in: PubMed
    Score: 0.038
  44. Nonsteroidal anti-inflammatory drug use in dentistry: gastrointestinal implications. Gen Dent. 1999 Nov-Dec; 47(6):590-6; quiz 597-8.
    View in: PubMed
    Score: 0.037
  45. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999 Jul; 37(7):2274-9.
    View in: PubMed
    Score: 0.037
  46. Diagnosis and management of Helicobacter pylori infection. Clin Cornerstone. 1999; 1(5):18-28.
    View in: PubMed
    Score: 0.035
  47. How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol. 1998 Apr; 93(4):553-61.
    View in: PubMed
    Score: 0.033
  48. Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. Aliment Pharmacol Ther. 1997 Oct; 11(5):939-42.
    View in: PubMed
    Score: 0.032
  49. Comparison of agar gel (CLOtest) or reagent strip (PyloriTek) rapid urease tests for detection of Helicobacter pylori infection. Am J Gastroenterol. 1997 Jun; 92(6):997-9.
    View in: PubMed
    Score: 0.032
  50. Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. Am J Gastroenterol. 1995 Sep; 90(9):1411-4.
    View in: PubMed
    Score: 0.028
  51. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. Am J Gastroenterol. 1995 Mar; 90(3):403-5.
    View in: PubMed
    Score: 0.027
  52. Determination of Helicobacter pylori status by reverse transcription-polymerase chain reaction. Comparison with urea breath test. Dig Dis Sci. 1995 Jan; 40(1):109-13.
    View in: PubMed
    Score: 0.027
  53. Clarithromycin-amoxycillin therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1994 Aug; 8(4):453-6.
    View in: PubMed
    Score: 0.026
  54. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol. 1994 Aug; 89(8):1203-5.
    View in: PubMed
    Score: 0.026
  55. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol. 1993 Aug; 28(8):690-4.
    View in: PubMed
    Score: 0.024
  56. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol. 1990 Aug; 85(8):944-8.
    View in: PubMed
    Score: 0.020
  57. Campylobacter pylori. The organism and its clinical relevance. J Clin Gastroenterol. 1989; 11 Suppl 1:S43-8.
    View in: PubMed
    Score: 0.018
  58. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol. 1988 Oct; 83(10):1081-4.
    View in: PubMed
    Score: 0.017
  59. Should I search for Campylobacter pylori in my patients? Much ado about not much? Am J Gastroenterol. 1988 May; 83(5):481-3.
    View in: PubMed
    Score: 0.017
  60. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt. Scand J Infect Dis. 2008; 40(9):730-3.
    View in: PubMed
    Score: 0.016
  61. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol. 1987 Nov; 82(11):1153-8.
    View in: PubMed
    Score: 0.016
  62. Campylobacter pyloridis gastritis: the past, the present, and speculations about the future. Am J Gastroenterol. 1987 Apr; 82(4):283-6.
    View in: PubMed
    Score: 0.016
  63. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004 Oct; 9(5):453-9.
    View in: PubMed
    Score: 0.013
  64. The role of the clinician in research. Am J Gastroenterol. 1984 May; 79(5):335-40.
    View in: PubMed
    Score: 0.013
  65. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter. 2003 Dec; 8(6):626-42.
    View in: PubMed
    Score: 0.012
  66. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000. Curr Pharm Des. 2000 Oct; 6(15):1503-14.
    View in: PubMed
    Score: 0.010
  67. Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori. Helicobacter. 1999 Sep; 4(3):154-61.
    View in: PubMed
    Score: 0.009
  68. Geographical pathology of Helicobacter pylori infection: is there more than one gastritis? Ann Med. 1995 Oct; 27(5):595-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.